← Leaderboards
Lauren A Hoffman
Massachusetts General Hospital
$977,001
Attributed
$977,001
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $200.8K · FY2019–25$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$977,001 · 2
By mechanism
K01$752,771 · 1
F32$224,230 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- John F Kelly$11,770,608
- Steven A Safren$27,216,676
- Margarita Alegria$41,708,508
- Simon N Powell$16,981,652
- Stephen V Faraone$22,345,408
Others in their field
Other Emerging Leaders on “Mentors”
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Molly Wasko · University Of Alabama At Birmingham$18,626,873
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$14,442,706
- Mark Brian Reed · San Diego State University$13,246,314
Research focus
MentorsClinically RelevantLinkProgramsOpioid Use DisorderAdherenceDisease RemissionImpairmentPharmacotherapyPharmaceutical PreparationsPublic HealthRecoveryTherapy DevelopmentTrainingDesignAwardFoundationsFutureBuprenorphineRecruitBuprenorphine TreatmentAssertivenessAreaAffect
Grant awards (8)
Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers$197,425
K01 · FY2025 · DA · contact PI
Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers$185,141
K01 · FY2024 · DA · contact PI
Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers$184,991
K01 · FY2023 · DA · contact PI
Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers$185,214
K01 · FY2022 · DA · contact PI
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients [SUPPLEMENT]$15,632
F32 · FY2022 · DA · contact PI
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients$73,062
F32 · FY2021 · DA · contact PI
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients$69,810
F32 · FY2020 · DA · contact PI
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients$65,726
F32 · FY2019 · DA · contact PI